Many incoming college students must take the meningococcal vaccine or risk not being admitted to their school.
But 41 percent of the vaccine's recipients report headaches, 35 percent report fatigue, and 20 percent report aches and pains in their joints.
In addition, the vaccine does not protect against one-third of the strains of the disease, and does not guarantee immunity against any strains.
Less than 1 in 100,000 contract the meningococcal meningitis disease annually in the United States and 50% of those cases are in infants. Of those who do contract the disease, most recover fully and fatalities are in less than 10% of the case.